Chronic Illness Info Line entered the industry of Blood Related Health Services in 1996 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621991, which describes it as a Blood Related Health Services. For further clarification, the SIC classifies this business under the code 8099 and described it as a Blood Related Health Services. The business provides service to the B2C market.
To acquire more information, please contact Carol Lynn by calling (559) 438-4515 during business hours. You can also write to the business’ Single Location at 1515 Locust St # 709, Pittsburgh, Pennsylvania PA 15219. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Chronic Illness Info Line |
| Representative: | Carol Lynn |
| Place of Business: | 1515 Locust St # 709, Pittsburgh, PA 15219 |
| Contact Number: | (559) 438-4515 |
| Type of Service: | Blood Related Health Services |
| SIC Number: | 8099 |
| NAICS Number: | 621991 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 1996 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Chronic Illness Info Line is a company operating from Allegheny, Pennsylvania providing professional Blood Related Health Services and relevant B2C variables. It was founded in 1996 and registered with the SIC code 8099 as Blood Related Health Services, and with the NAICS code 621991 as Blood Related Health Services.
With a current employee count of 1 to 4, Chronic Illness Info Line has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Carol Lynn at (559) 438-4515 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 1515 Locust St # 709 in Pittsburgh, Pennsylvania 15219 and can be engaged online through the company website at , the company Twitter , and Facebook page .